These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9828102)

  • 41. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
    Stordal BK; Davey MW; Davey RA
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cisplatin-induced nitrosylation of p53 prevents its mitochondrial translocation.
    Hernlund E; Kutuk O; Basaga H; Linder S; Panaretakis T; Shoshan M
    Free Radic Biol Med; 2009 Jun; 46(12):1607-13. PubMed ID: 19328230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of DNA methyltransferase reverses cisplatin induced drug resistance in murine neuroblastoma cells.
    Qiu YY; Mirkin BL; Dwivedi RS
    Cancer Detect Prev; 2005; 29(5):456-63. PubMed ID: 16185816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells.
    Marverti G; Ligabue A; Paglietti G; Corona P; Piras S; Vitale G; Guerrieri D; Luciani R; Costi MP; Frassineti C; Moruzzi MS
    Eur J Pharmacol; 2009 Aug; 615(1-3):17-26. PubMed ID: 19446547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.
    Welters MJ; Fichtinger-Schepman AM; Baan RA; Jacobs-Bergmans AJ; Kegel A; van der Vijgh WJ; Braakhuis BJ
    Br J Cancer; 1999 Jan; 79(1):82-8. PubMed ID: 10408697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential osteogenic differentiation of cisplatin-resistant rat malignant fibrous histiocytoma-derived cell lines.
    Yamate J; Kotera T; Kuwamura M; Kotani T
    Exp Toxicol Pathol; 2007 Apr; 58(5):299-309. PubMed ID: 17267196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remodeling of vimentin cytoskeleton correlates with enhanced motility of promyelocytic leukemia cells during differentiation induced by retinoic acid.
    Bruel A; Paschke S; Jainta S; Zhang Y; Vassy J; Rigaut JP; Beil M
    Anticancer Res; 2001; 21(6A):3973-80. PubMed ID: 11911279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phospholipase A2-activating protein (PLAA) enhances cisplatin-induced apoptosis in HeLa cells.
    Zhang F; Suarez G; Sha J; Sierra JC; Peterson JW; Chopra AK
    Cell Signal; 2009 Jul; 21(7):1085-99. PubMed ID: 19258036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitochondria in living cells cultured from human chorionic villi: the effects of colchicine on numbers and distribution.
    Addai FK; Ockleford CD
    J Anat; 1986 Aug; 147():219-33. PubMed ID: 3319997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro effects of styrene on cytoskeletal apparatus: an immunocytochemical study.
    Malorni W; Formisano G; Iosi F
    Drug Chem Toxicol; 1988; 11(4):419-31. PubMed ID: 3072173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of microtubules and intermediate filaments on mitochondrial distribution.
    Summerhayes IC; Wong D; Chen LB
    J Cell Sci; 1983 May; 61():87-105. PubMed ID: 6350334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Opioids and monocyte function in chronic hepatitis B].
    Prieto J; Castilla A; Subirá ML; Civeira MP
    Med Clin (Barc); 1989 Jun; 93(4):157. PubMed ID: 2796439
    [No Abstract]   [Full Text] [Related]  

  • 54. An in vivo intermediate filament assembly model.
    Portet S; Arino J
    Math Biosci Eng; 2009 Jan; 6(1):117-34. PubMed ID: 19292511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Editorial overview: cell architecture: intermediate filaments - from molecules to patients.
    Hol EM; Etienne-Manneville S
    Curr Opin Cell Biol; 2015 Feb; 32():v-vi. PubMed ID: 25666354
    [No Abstract]   [Full Text] [Related]  

  • 56. Is the function of neurofilaments modified by sensory input?
    Elomaa E; Virtanen I
    Med Hypotheses; 1986 Apr; 19(4):339-40. PubMed ID: 2423857
    [No Abstract]   [Full Text] [Related]  

  • 57. L-Carnitine Mitigates Oxidative Stress and Disorganization of Cytoskeleton Intermediate Filaments in Cisplatin-Induced Hepato-Renal Toxicity in Rats.
    Elkomy A; Abdelhiee EY; Fadl SE; Emam MA; Gad FA; Sallam A; Alarifi S; Abdel-Daim MM; Aboubakr M
    Front Pharmacol; 2020; 11():574441. PubMed ID: 33117167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.
    Kozubík A; Vaculová A; Soucek K; Vondrácek J; Turánek J; Hofmanová J
    Met Based Drugs; 2008; 2008():417897. PubMed ID: 18414587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells.
    Nowak G
    J Biol Chem; 2002 Nov; 277(45):43377-88. PubMed ID: 12218054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cisplatin induced intermediate filament reorganization and altered mitochondrial function in 3T3 cells and drug-sensitive and -resistant Walker 256 cells.
    Evans RM; Simpkins H
    Exp Cell Res; 1998 Nov; 245(1):69-78. PubMed ID: 9828102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.